vs

Side-by-side financial comparison of ALLIANCE ENTERTAINMENT HOLDING CORP (AENT) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

ALLIANCE ENTERTAINMENT HOLDING CORP is the larger business by last-quarter revenue ($368.7M vs $321.1M, roughly 1.1× MADRIGAL PHARMACEUTICALS, INC.). ALLIANCE ENTERTAINMENT HOLDING CORP runs the higher net margin — 2.5% vs -18.2%, a 20.8% gap on every dollar of revenue. On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs -6.3%). ALLIANCE ENTERTAINMENT HOLDING CORP produced more free cash flow last quarter ($-16.9M vs $-133.8M).

Alliance Atlantis Communications Inc. was a media company that operated primarily as a specialty service provider in Canada. Primarily based in Toronto, Alliance Atlantis also had offices in Halifax, Los Angeles, London, Dublin, Madrid, Barcelona, Shannon, and Sydney.

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

AENT vs MDGL — Head-to-Head

Bigger by revenue
AENT
AENT
1.1× larger
AENT
$368.7M
$321.1M
MDGL
Growing faster (revenue YoY)
MDGL
MDGL
+217.1% gap
MDGL
210.8%
-6.3%
AENT
Higher net margin
AENT
AENT
20.8% more per $
AENT
2.5%
-18.2%
MDGL
More free cash flow
AENT
AENT
$117.0M more FCF
AENT
$-16.9M
$-133.8M
MDGL

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
AENT
AENT
MDGL
MDGL
Revenue
$368.7M
$321.1M
Net Profit
$9.4M
$-58.6M
Gross Margin
Operating Margin
4.7%
-18.6%
Net Margin
2.5%
-18.2%
Revenue YoY
-6.3%
210.8%
Net Profit YoY
32.8%
1.4%
EPS (diluted)
$0.18
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AENT
AENT
MDGL
MDGL
Q4 25
$368.7M
$321.1M
Q3 25
$254.0M
$287.3M
Q2 25
$227.8M
$212.8M
Q1 25
$213.0M
$137.3M
Q4 24
$393.7M
$103.3M
Q3 24
$229.0M
$62.2M
Q2 24
$236.9M
Q1 24
$211.2M
$0
Net Profit
AENT
AENT
MDGL
MDGL
Q4 25
$9.4M
$-58.6M
Q3 25
$4.9M
$-114.2M
Q2 25
$5.8M
$-42.3M
Q1 25
$1.9M
$-73.2M
Q4 24
$7.1M
$-59.4M
Q3 24
$397.0K
$-107.0M
Q2 24
$2.5M
Q1 24
$-3.4M
$-147.5M
Gross Margin
AENT
AENT
MDGL
MDGL
Q4 25
Q3 25
Q2 25
Q1 25
96.7%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
AENT
AENT
MDGL
MDGL
Q4 25
4.7%
-18.6%
Q3 25
4.2%
-39.7%
Q2 25
4.3%
-22.2%
Q1 25
1.7%
-57.8%
Q4 24
3.8%
-64.8%
Q3 24
0.9%
-187.1%
Q2 24
0.2%
Q1 24
-0.3%
Net Margin
AENT
AENT
MDGL
MDGL
Q4 25
2.5%
-18.2%
Q3 25
1.9%
-39.8%
Q2 25
2.5%
-19.9%
Q1 25
0.9%
-53.4%
Q4 24
1.8%
-57.5%
Q3 24
0.2%
-172.0%
Q2 24
1.1%
Q1 24
-1.6%
EPS (diluted)
AENT
AENT
MDGL
MDGL
Q4 25
$0.18
$-2.55
Q3 25
$0.10
$-5.08
Q2 25
$0.11
$-1.90
Q1 25
$0.04
$-3.32
Q4 24
$0.14
$-2.50
Q3 24
$0.01
$-4.92
Q2 24
$0.05
Q1 24
$-0.07
$-7.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AENT
AENT
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$198.7M
Total DebtLower is stronger
$339.9M
Stockholders' EquityBook value
$117.6M
$602.7M
Total Assets
$434.1M
$1.3B
Debt / EquityLower = less leverage
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AENT
AENT
MDGL
MDGL
Q4 25
$198.7M
Q3 25
$295.7M
Q2 25
$186.2M
Q1 25
$183.6M
Q4 24
$100.0M
Q3 24
$4.3M
$232.7M
Q2 24
$1.1M
Q1 24
$1.6M
$622.5M
Total Debt
AENT
AENT
MDGL
MDGL
Q4 25
$339.9M
Q3 25
$339.8M
Q2 25
$118.4M
Q1 25
$118.0M
Q4 24
$117.6M
Q3 24
$117.1M
Q2 24
Q1 24
$116.1M
Stockholders' Equity
AENT
AENT
MDGL
MDGL
Q4 25
$117.6M
$602.7M
Q3 25
$108.1M
$625.7M
Q2 25
$103.2M
$696.0M
Q1 25
$97.4M
$710.6M
Q4 24
$95.6M
$754.4M
Q3 24
$88.0M
$777.2M
Q2 24
$87.6M
Q1 24
$85.1M
$850.8M
Total Assets
AENT
AENT
MDGL
MDGL
Q4 25
$434.1M
$1.3B
Q3 25
$383.0M
$1.4B
Q2 25
$361.2M
$1.0B
Q1 25
$349.4M
$996.6M
Q4 24
$401.7M
$1.0B
Q3 24
$395.7M
$1.1B
Q2 24
$340.8M
Q1 24
$324.0M
$1.1B
Debt / Equity
AENT
AENT
MDGL
MDGL
Q4 25
0.56×
Q3 25
0.54×
Q2 25
0.17×
Q1 25
0.17×
Q4 24
0.16×
Q3 24
0.15×
Q2 24
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AENT
AENT
MDGL
MDGL
Operating Cash FlowLast quarter
$-16.5M
$-133.5M
Free Cash FlowOCF − Capex
$-16.9M
$-133.8M
FCF MarginFCF / Revenue
-4.6%
-41.7%
Capex IntensityCapex / Revenue
0.1%
0.1%
Cash ConversionOCF / Net Profit
-1.76×
TTM Free Cash FlowTrailing 4 quarters
$-1.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AENT
AENT
MDGL
MDGL
Q4 25
$-16.5M
$-133.5M
Q3 25
$2.7M
$79.8M
Q2 25
$10.7M
$-47.1M
Q1 25
$2.5M
$-88.9M
Q4 24
$25.3M
$-104.5M
Q3 24
$-11.6M
$-67.0M
Q2 24
$9.7M
Q1 24
$20.0M
$-149.2M
Free Cash Flow
AENT
AENT
MDGL
MDGL
Q4 25
$-16.9M
$-133.8M
Q3 25
$2.4M
$79.0M
Q2 25
$10.7M
Q1 25
$2.4M
Q4 24
$-104.7M
Q3 24
$-11.6M
$-67.8M
Q2 24
Q1 24
$20.0M
$-149.5M
FCF Margin
AENT
AENT
MDGL
MDGL
Q4 25
-4.6%
-41.7%
Q3 25
0.9%
27.5%
Q2 25
4.7%
Q1 25
1.1%
Q4 24
-101.3%
Q3 24
-5.1%
-109.0%
Q2 24
Q1 24
9.4%
Capex Intensity
AENT
AENT
MDGL
MDGL
Q4 25
0.1%
0.1%
Q3 25
0.1%
0.3%
Q2 25
0.0%
0.0%
Q1 25
0.0%
0.0%
Q4 24
0.0%
0.2%
Q3 24
0.0%
1.3%
Q2 24
Q1 24
0.0%
Cash Conversion
AENT
AENT
MDGL
MDGL
Q4 25
-1.76×
Q3 25
0.56×
Q2 25
1.86×
Q1 25
1.33×
Q4 24
3.57×
Q3 24
-29.31×
Q2 24
3.85×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AENT
AENT

Segment breakdown not available.

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons